Thierry Guillot
About
In The Last Decade
Thierry Guillot
21 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 872
- Pulmonary and Respiratory Medicine 338
- Surgery 275
- Hepatology 178
- Pathology and Forensic Medicine 148
Countries citing papers authored by Thierry Guillot
This map shows the geographic impact of Thierry Guillot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Guillot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Guillot more than expected).
Fields of papers citing papers by Thierry Guillot
This network shows the impact of papers produced by Thierry Guillot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Guillot. The network helps show where Thierry Guillot may publish in the future.
Co-authorship network of co-authors of Thierry Guillot
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Guillot. A scholar is included among the top collaborators of Thierry Guillot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Guillot. Thierry Guillot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. breakdown → | 709 |
| 3 | 26 | |
| 4 | 16 | |
| 5 | 20 | |
| 6 | 2 | |
| 7 | 49 | |
| 8 | 14 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 2 | |
| 13 | 50 | |
| 14 | 6 | |
| 15 | 9 | |
| 16 | 1 | |
| 17 | 15 | |
| 18 | 41 | |
| 19 | 3 | |
| 20 | [Epidermoid cancer of the esophagus: is the combination of chemotherapy then surgery beneficial?]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.